Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2017.04.013DOI Listing

Publication Analysis

Top Keywords

corrigendum "first
4
"first treatment
4
treatment pemphigus
4
pemphigus vulgaris
4
vulgaris novel
4
novel protocol
4
protocol patients
4
patients contraindications
4
contraindications systemic
4
systemic corticosteroids
4

Similar Publications

Corrigendum to "Stress systems exacerbate the inflammatory response after corneal abrasion in sleep-deprived mice via the IL-17 signaling pathway" [Mucosal Immunol. 17(3) (2024) 323-345].

Mucosal Immunol

January 2025

International Ocular Surface Research Center, Institute of Ophthalmology and Key Laboratory for Regenerative Medicine, Jinan University Medical School, Guangzhou, China; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China. Electronic address:

View Article and Find Full Text PDF

Corrigendum: Viable but nonculturable state in the zoonotic pathogen induced by low-grade fever temperature and antibiotic treatment.

Front Cell Infect Microbiol

January 2025

Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

[This corrects the article DOI: 10.3389/fcimb.2024.

View Article and Find Full Text PDF

Corrigendum to "Early enriched physical environment reverses impairments of the hippocampus, but not medial prefrontal cortex, of socially-isolated mice" [Brain Behav. Immun. 64 (2017) 232-243].

Brain Behav Immun

January 2025

Jiangsu Key Laboratory of Neurodegeneration, Nanjing Medical University, No. 101 Longmian Avenue, Nanjing, Jiangsu 211166, China; Jiangsu Key Laboratory of Gerontology, the First Affiliated Hospital, Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, Jiangsu 210029, China. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!